Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Indirect comparison of linvoseltamab versus teclistamab for triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM).

View Full Paper
Ask AI
Bookmark
Share

Authors

SJSundar JagannathHLHans C. LeeJRJoshua Richter

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jagannath et al. (2024) studied this question.

synapsesocial.com/papers/68e66db4b6db6435875f86a0https://doi.org/10.1200/jco.2024.42.16_suppl.7560
View Full Paper
Ask AI
Bookmark
Share